SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : DYAX: Dyax Corp. -- Ignore unavailable to you. Want to Upgrade?


To: keokalani'nui who wrote (55)3/14/2003 1:30:26 PM
From: keokalani'nui  Read Replies (1) | Respond to of 197
 
Maybe decided to take down the x88 cardio indication?

Dyax Announces Sale of Common Stock
Friday March 14, 12:58 pm ET

CAMBRIDGE, Mass.--(BUSINESS WIRE)--March 14, 2003--Dyax Corp. (Nasdaq:DYAX - News) announced today that it has entered into agreements to sell 4,721,625 shares of its common stock to selected institutional and other accredited investors at $1.86 per share. The offering was priced at 10% above the average closing price of Dyax traded shares for the preceding five days.